CIA
NVS icon

Compass Ion Advisors’s Novartis NVS Stock Holding History

Compass Ion Advisors’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$401K Sell
2,560
-31
-1% -$4.65K 0.03% 211
2026
Q1 		$396K Buy
2,591
+31
+1% +$4.75K 0.04% 200
2025
Q4 		$353K Sell
2,560
-164
-6% -$21.5K 0.03% 204
2025
Q3 		$349K Buy
2,724
+149
+6% +$18.2K 0.03% 207
2025
Q2 		$312K Hold
2,575
– – 0.03% 207
2025
Q1 		$287K Hold
2,575
– – 0.03% 213
2024
Q4 		$251K Sell
2,575
-82
-3% -$8.74K 0.03% 228
2024
Q3 		$306K Sell
2,657
-47
-2% -$5.33K 0.04% 205
2024
Q2 		$262K Hold
2,704
– – 0.04% 199
2024
Q1 		$262K Hold
2,704
– – 0.04% 199
2023
Q4 		$273K Sell
2,704
-233
-8% -$22.5K 0.04% 197
2023
Q3 		$299K Buy
+2,937
New +$298K 0.05% 186
2020
Q4 		– Sell
-2,768
Closed -$241K – 90
2020
Q3 		$241K Buy
+2,768
New +$240K 0.15% 70

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Compass Ion Advisors's NVS Position: Q2 2026 in Review

Compass Ion Advisors reduced its Novartis (NVS) stake by 1.2% in Q2 2026, selling an estimated $4.65K and leaving 2,560 shares worth $401K. The position accounts for 0.03% of the portfolio, ranked #211.

Compass Ion Advisors first reported a position in NVS in Q3 2020 and has held it in 13 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Compass Ion Advisors held 2,560 shares of Novartis worth $401K as of Q2 2026.
  • Compass Ion Advisors sold 31 Novartis shares in Q2 2026, an estimated $4.65K.
  • Novartis made up 0.03% of Compass Ion Advisors's portfolio in Q2 2026, its #211 holding.
  • Compass Ion Advisors first reported a position in Novartis in Q3 2020 and has held it in 13 quarters since.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Compass Ion Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.